TickerFacts.

Immucell Corp (ICCC): Cash & Equivalents

Annual figures by period end, from SEC filings.

$3.81M
As of 2025-12-31
$8.86M
As of 2026-06-30
-13.1%
3-year compound annual growth
-11.3%
5-year compound annual growth
+9.2%
10-year compound annual growth
$10.19M2009-12-31: $975.5K2010-12-31: $1.40M2011-12-31: $781.5K2012-12-31: $2.67M2013-12-31: $2.27M2014-12-31: $850.0K2015-12-31: $1.57M2016-12-31: $5.15M2017-12-31: $3.80M2018-12-31: $2.52M2019-12-31: $6.29M2020-12-31: $6.95M2021-12-31: $10.19M2022-12-31: $5.79M2023-12-31: $978.7K2024-12-31: $3.76M2025-12-31: $3.81M$3.81M
2009-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$3.81M+1.3%2026-03-30, Balance as of period end
2024-12-31$3.76M+284.0%2026-03-30, Balance as of period end
2023-12-31$978.7K-83.1%2024-04-01, Balance as of period end
2022-12-31$5.79M-43.1%2024-04-01, Balance as of period end
2021-12-31$10.19M+46.6%2023-03-29, Balance as of period end
2020-12-31$6.95M+10.4%2022-03-30, Balance as of period end
2019-12-31$6.29M+149.6%2021-03-30, Balance as of period end
2018-12-31$2.52M-33.6%2020-03-27, Balance as of period end
2017-12-31$3.80M-26.2%2019-03-22, Balance as of period end
2016-12-31$5.15M+227.4%2018-03-29, Balance as of period end
2015-12-31$1.57M+85.1%2017-03-30, Balance as of period end
2014-12-31$850.0K-62.6%2016-03-25, Balance as of period end
2013-12-31$2.27M-15.1%2016-03-25, Balance as of period end
2012-12-31$2.67M+242.1%2015-03-26, Balance as of period end
2011-12-31$781.5K-44.1%2014-03-26, Balance as of period end
2010-12-31$1.40M+43.4%2013-03-28, Balance as of period end
2009-12-31$975.5Kn/a2012-03-27, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Immucell Corp (ICCC)2025-12-31$3.81M+1.3%
Alpha Teknova, Inc. (TKNO)2025-12-31$5.91M+59.4%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$155.46M-17.8%
Aspira Women's Health Inc. (AWHL)2025-12-31$1.75M-0.8%
Anbio Biotechnology (NNNN)2025-12-31$7.77M-34.0%
Biomerica Inc (BMRA)2026-05-31$1.31M-45.5%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$11.58M+34.1%
Volitionrx Ltd (VNRX)2025-12-31$1.12M-65.8%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$28.87M+1.8%

Compare ICCC, TKNO, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗